To elucidate the cellular role of DNMT3B in the activation of HSCs during the development of liver fibrosis, we observed the morphological changes in HSCs induced by inhibition of DNMT3B with siDNMT3B after TGF-β1 treatment. This evidence concerns the gene TGFB1 and Hepatic fibrosis.